Bile acid sequestrants improve glycemic control in type 2 diabetes: A proposed mechanism implicating glucagon-like peptide 1 release

Hepatology

Volumn 53, Issue 5, 2011, Pages 1784-

  Hofmann, Alan F ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLESEVELAM; GLUCAGON LIKE PEPTIDE 1;

BILE ACID METABOLISM; DRUG MECHANISM; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; INSULIN RESISTANCE; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN SECRETION;

ALLYLAMINE; ANTICHOLESTEREMIC AGENTS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; GLUCAGON-LIKE PEPTIDE 1; HUMANS;

EID: 79955111608     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24100     Document Type: Letter

References (6)

1. Brufau G, Stellaard F, Prado K, Bloks VW, Jonkers E, Boverhof R, et al. Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism. HEPATOLOGY 2011; 52: 1455-1464.
2. Poley JR, Hofmann AF. Role of fat maldigestion in pathogenesis of steatorrhea in ileal resection. Fat digestion after two sequential test meals with and without cholestyramine. Gastroenterology 1976; 71: 38-44.
3. Hoffman NE, Hofmann AF. A comparison of the rate of absorption of micellar and nonmicellar oleic acid: a jejuna perfusion study in man. Am J Dig Dis 1973; 18: 489-492.
4. Knoebel LK. Intestinal absorption of micellar and nonmicellar lipid. Am J Physiol 1972; 223: 255-261.
5. Beglinger S, Drewe J, Schirra J, Göke B, D'Amato M, Beglinger C. Role of fat hydrolysis in regulating glucagon-like peptide-1 secretion. J Clin Endocrinol Metab 2011; 95: 879-886.
6. Thomas C, Gioiello A, Noriega L, Strehle A, Oury J, Rizzo G, et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 2009; 10: 167-177.